Literature DB >> 19207748

Favorable outcome using an abbreviated procedure for catheter ablation of AVNRT: results from a prospective randomized trial.

Daniel Steven1, Thomas Rostock, Boris A Hoffmann, Helge Servatius, Imke Drewitz, Kai Müllerleile, Hanno Klemm, Carsten Melchert, Karl Wegscheider, Thomas Meinertz, Stephan Willems.   

Abstract

INTRODUCTION: Radiofrequency catheter ablation aiming slow pathway modulation is a widely established procedure with high success and low recurrence rates in patients with atrioventricular nodal reentry tachycardia (AVNRT). However, the necessity of a waiting period following successful slow pathway modulation to increase the long-term success rates has not been systematically evaluated thus far. METHODS AND
RESULTS: This prospective study comprised 138 consecutive patients (mean age 50.3 +/- 15.1 years) with AVNRT. These patients were randomly assigned to two groups: in group I (n = 70), a waiting period of 30 min was part of the procedure, whereas in group II (n = 68), the procedure ended without a waiting period. Electrophysiological standard parameters, i.e., ERP of RA, fast and slow pathway, RV as well as antegrade and retrograde AV node conduction capacity, were assessed prior to and after the ablation. During a follow-up period of 22.8 +/- 5.9 months, four patients in group I and three patients in group II developed recurrence of AVNRT (4.9%; P = 0.4). The mean procedure time was 115.1 +/- 23.6 min in the group with and 88.9 +/- 23.3 min in the group without waiting period (P = 0.009). No high degree AV-node conduction block was observed during the study.
CONCLUSION: In the present study we could show that no long-term benefit results from a 30 min waiting period for patients who underwent an acutely successful catheter ablation for AVNRT. We therefore conclude that a 30-min waiting period can be omitted in standard procedures, thus resulting in significant shorter procedure durations.

Entities:  

Mesh:

Year:  2008        PMID: 19207748     DOI: 10.1111/j.1540-8167.2008.01372.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Role of isoproterenol in predicting the success of catheter ablation in patients with reproducibly inducible atrioventricular nodal reentrant tachycardia.

Authors:  Alireza Heydari; Mohammad Tayyebi; Rahmatolah Damanpak Jami; Asgar Amiri
Journal:  Tex Heart Inst J       Date:  2014-06-01

Review 2.  [How to approach the patient with supraventricular tachycardia in the EP lab: A systematic overview].

Authors:  D Steven; H Bonnemeier; T Deneke; H L Estner; C Kriatselis; M Kuniss; A Luik; H-R Neuberger; D-I Shin; P Sommer; R R Tilz; D Thomas; C von Bary; F Voss; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-02

3.  Multicenter, randomized comparison between magnetically navigated and manually guided radiofrequency ablation of atrioventricular nodal reentrant tachycardia (the MagMa-AVNRT-trial).

Authors:  Tilko Reents; Clemens Jilek; Peter Schuster; Georg Nölker; Katharina Koch-Büttner; Sonia Ammar-Busch; Verena Semmler; Felix Bourier; Marc Kottmaier; Marie Kornmayer; Stephanie Brooks; Stephanie Fichtner; Christof Kolb; Isabel Deisenhofer; Gabriele Hessling
Journal:  Clin Res Cardiol       Date:  2017-08-28       Impact factor: 5.460

Review 4.  Cryoablation Versus Radiofrequency Ablation in AVNRT: Same Goal, Different Strategy.

Authors:  Riahi Leila; Prisecaru Raluca; De Greef Yves; Stockman Dirk; Schwagten Bruno
Journal:  J Atr Fibrillation       Date:  2015-06-30

5.  Cryoablation of an atrioventricular nodal reentrant tachycardia in a patient with an implanted deep brain stimulator.

Authors:  Melanie Gunawardene; Christian Meyer; Stephan Willems; Boris Alexander Hoffmann
Journal:  HeartRhythm Case Rep       Date:  2016-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.